A Study of Subcutaneous Recombinant Human hetIL-15 (IL15/sIL-15Ra) in Adults With Metastatic Cancers

Clinical Trial ID NCT02452268

PubWeight™ 3.04‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02452268

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 2015 1.54
2 The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis. Stem Cell Rev 2015 0.84
3 IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. Cancer Res 2015 0.81
Next 100